PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550580
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550580
The Global Blood Flow Measurement Devices Market is estimated to be valued at USD 810.5 Mn in 2024 and is expected to reach USD 1,495.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 810.5 Mn |
Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
Forecast Period 2024 to 2031 CAGR: | 9.10% | 2031 Value Projection: | US$ 1,495.1 Mn |
The global blood flow measurement devices market has been gaining significant traction over the past couple of years owing to growing prevalence of cardiovascular diseases worldwide. Rising number of patients suffering from heart conditions like heart failure, coronary artery disease etc has boosted demand for advanced blood flow measurement devices that helps achieve accurate diagnosis. Constant technological advancements in medical devices industry has led to development of non-invasive and minimally-invasive blood flow measurement solutions. Adoption of digital healthcare and integration of artificial intelligence further complements the blood flow analysis. Continuous research activities to develop reliable and affordable blood flow monitoring systems will reportedly aid the market expansion through 2030.
Growing geriatric population base suffering from chronic heart diseases around the globe acts as a key growth driver. According to WHO, cardiovascular illnesses account for over 17 million yearly deaths representing one third of all global deaths. This has prompted governments to increase public healthcare spending which benefits market players. However, expensive price tags of technologically sophisticated blood flow measurement devices especially for patients in low-income nations continues to deter their widespread adoption to some extent. On the brighter side, ongoing R&D to create cost-effective product variants suitable for resource-poor setups provides new opportunities in emerging countries. Rising investments by both public and private sectors in medical technology development is anticipated to further fuel the market demand.
This report provides in-depth analysis of the global blood flow measurement devices market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global blood flow measurement devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medistim, Cook Medical Inc., Getinge Group, Deltex Medical Group, Transonic Systems, Compumedics, Adinstruments, Sonotec Ultraschallsensorik Halle, Biopac Systems, Moor Instruments, and Atys Medical
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global blood flow measurement devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood flow measurement devices market.
Detailed Segmentation-